GlaxoSmithKline PLC
A global biopharma company developing medicines and vaccines to prevent and treat disease.
GSK | IL
Overview
Corporate Details
- ISIN(s):
- GB0009252882 (+2 more)
- LEI:
- 5493000HZTVUYLO1D793
- Country:
- United Kingdom
- Address:
- 79 NEW OXFORD STREET, WC1A 1DG LONDON
- Website:
- https://www.gsk.com/en-gb/
- Sector:
- Manufacturing
Description
GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-23 13:16 |
GSK TO LOWER DRUG PRICES AND EXPAND ACCESS IN US
|
English | 12.0 KB | ||
| 2025-12-22 18:23 |
DIRECTOR/PDMR SHAREHOLDING
|
English | 13.5 KB | ||
| 2025-12-22 16:40 |
Director/PDMR Shareholding
|
English | 75.6 KB | ||
| 2025-12-22 12:12 |
TRANSACTION IN OWN SHARES
|
English | 90.2 KB | ||
| 2025-12-22 08:20 |
GSK to lower drug prices and expand access in US
|
English | 19.8 KB | ||
| 2025-12-22 08:10 |
Transaction in Own Shares
|
English | 1015.7 KB | ||
| 2025-12-19 12:51 |
TRANSACTION IN OWN SHARES
|
English | 80.9 KB | ||
| 2025-12-19 08:15 |
Transaction in Own Shares
|
English | 854.1 KB | ||
| 2025-12-18 12:04 |
TRANSACTION IN OWN SHARES
|
English | 98.4 KB | ||
| 2025-12-18 08:15 |
Transaction in Own Shares
|
English | 1.0 MB | ||
| 2025-12-17 13:10 |
EXDENSUR (DEPEMOKIMAB ULLA) APPROVED BY US FDA
|
English | 20.1 KB | ||
| 2025-12-17 12:31 |
TRANSACTION IN OWN SHARES
|
English | 89.0 KB | ||
| 2025-12-17 08:25 |
Exdensur (depemokimab ulla) approved by US FDA
|
English | 33.7 KB | ||
| 2025-12-17 08:20 |
Transaction in Own Shares
|
English | 958.7 KB | ||
| 2025-12-16 14:51 |
EXDENSUR (DEPEMOKIMAB) UK MHRA APPROVAL
|
English | 20.9 KB |
Automate Your Workflow. Get a real-time feed of all GlaxoSmithKline PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GlaxoSmithKline PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GlaxoSmithKline PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
